To include your compound in the COVID-19 Resource Center, submit it here.

CPP-115: Phase I started

Catalyst began a 2-part, U.S. Phase Ib trial to evaluate single and multiple doses of

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE